We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
MacroGenics
MGNX
$259M
| $12.3M | ﹤0.01% |
2,656,010
+2,157
| +0.1% | +$8.16K |
|
2702
Chemung Financial Corp
CHMG
$399M
| $12.3M | ﹤0.01% |
164,331
-8,913
| -5% | -$597K |
|
2703
National CineMedia
NCMI
$237M
| $12.2M | ﹤0.01% |
3,221,372
-6,999
| -0.2% | -$23.8K |
|
2704
BK Technologies
BKTI
$287M
| $12.2M | ﹤0.01% |
141,906
+2,146
| +2% | +$186K |
|
2705
N-able
NABL
$618M
| $12.2M | ﹤0.01% |
3,320,148
-122,099
| -4% | -$508K |
|
|
PURR
2706
Hyperliquid Strategies Inc
PURR
$1.44B
| $12.2M | ﹤0.01% |
1,545,330
+159,444
| +12% | +$1.18M |
|
|
IRD
2707
Opus Genetics
IRD
$304M
| $12.2M | ﹤0.01% |
2,958,683
+508,696
| +21% | +$2.37M |
|
|
NMAX
2708
Newsmax Inc
NMAX
$1.48B
| $12.1M | ﹤0.01% |
+1,464,021
| New | +$10.5M |
|
|
LMRI
2709
Lumexa Imaging Holdings
LMRI
$1.13B
| $12.1M | ﹤0.01% |
1,070,325
+11,839
| +1% | +$108K |
|
|
EIKN
2710
Eikon Therapeutics
EIKN
$567M
| $12M | ﹤0.01% |
922,707
-46,724
| -5% | -$477K |
|
2711
Biglari Holdings Class B
BH
$1.25B
| $12M | ﹤0.01% |
28,185
-1,570
| -5% | -$490K |
|
2712
Fate Therapeutics
FATE
$314M
| $12M | ﹤0.01% |
4,445,536
+253,473
| +6% | +$469K |
|
|
AVBH
2713
Avidbank Holdings
AVBH
$359M
| $12M | ﹤0.01% |
362,951
+23,634
| +7% | +$720K |
|
2714
Electromed
ELMD
$333M
| $12M | ﹤0.01% |
283,232
-51,796
| -15% | -$1.66M |
|
|
TSSI
2715
TSS Inc
TSSI
$266M
| $11.9M | ﹤0.01% |
966,509
-1,931
| -0.2% | -$26K |
|
2716
First United
FUNC
$290M
| $11.9M | ﹤0.01% |
269,289
+332
| +0.1% | +$13K |
|
2717
Lineage Cell Therapeutics
LCTX
$268M
| $11.9M | ﹤0.01% |
9,054,918
+736,233
| +9% | +$1.02M |
|
2718
Energy Services of America
ESOA
$243M
| $11.8M | ﹤0.01% |
612,489
+25,814
| +4% | +$421K |
|
|
ISBA
2719
Isabella Bank
ISBA
$313M
| $11.8M | ﹤0.01% |
299,599
+25,551
| +9% | +$1.09M |
|
|
CBC
2720
Central Bancompany Inc
CBC
$7.8B
| $11.8M | ﹤0.01% |
387,537
+9,575
| +3% | +$260K |
|
2721
GoodRx Holdings
GDRX
$1.27B
| $11.8M | ﹤0.01% |
4,086,521
-174,995
| -4% | -$445K |
|
|
TWFG
2722
TWFG Inc
TWFG
$1.41B
| $11.8M | ﹤0.01% |
489,244
-81,293
| -14% | -$1.6M |
|
2723
Nathan's Famous
NATH
$400M
| $11.7M | ﹤0.01% |
115,510
-660
| -0.6% | -$66.8K |
|
|
EVMN
2724
Evommune Inc
EVMN
$517M
| $11.7M | ﹤0.01% |
881,895
+426,844
| +94% | +$9.92M |
|
|
SHOE
2725
Shoe Station Group
SHOE
$421M
| $11.7M | ﹤0.01% |
788,626
+15,288
| +2% | +$261K |
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.